Generate Biomedicines, Inc.
GENB
$15.64
$0.614.06%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 457.42M | 516.64M | -- | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 12.84M | 18.75M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 470.25M | 535.39M | -- | ||
|
|
|||||
| Total Current Assets | 470.25M | 535.39M | -- | ||
| Net Property, Plant & Equipment | 82.38M | 85.60M | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 9.06M | 4.75M | -- | ||
| Total Assets | 561.69M | 625.74M | -- | ||
|
|
|||||
| Total Accounts Payable | 5.55M | 7.52M | -- | ||
| Total Accrued Expenses | 22.78M | 16.95M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 13.62M | 14.26M | -- | ||
| Total Finance Division Other Current Liabilities | 14.69M | 19.66M | -- | ||
| Total Other Current Liabilities | 14.69M | 19.66M | -- | ||
| Total Current Liabilities | 56.64M | 58.39M | -- | ||
|
|
|||||
| Total Current Liabilities | 56.64M | 58.39M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 49.01M | 51.31M | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | 1.24M | -- | ||
| Total Liabilities | 105.65M | 110.94M | -- | ||
|
|
|||||
| Common Stock & APIC | 1.26B | 1.25B | -- | ||
| Retained Earnings | -804.99M | -737.74M | -- | ||
| Treasury Stock & Other | -129.00K | 24.00K | -- | ||
| Total Common Equity | 456.05M | 514.80M | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | 456.05M | 514.80M | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 456.05M | 514.80M | -- | ||
|
|
|||||